Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
21
ELVN Quote, Financials, Valuation and Earnings
Last price:
$16.27
Seasonality move
:
-8.68%
Day range:
$15.88 - $16.71
52-week range:
$13.30 - $25.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.03x
Volume:
510.9K
Avg. volume:
725.9K
1-year change:
-28.23%
Market cap:
$967.4M
Revenue:
--
EPS (TTM):
-$1.85
Earnings Data
Next earnings date for ELVN
Mar 12
2026
Most recent earnings per share
-$0.32
Beat by $0.14
(Nov 12/2025)
Consensus Estimate
-$0.47
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ELVN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/12/2026 | Q4 | $8.3K | -- | -- | -$0.50 | -- |
| 11/12/2025 | Q3 | -- | -- | -$0.32 | -$0.47 | $0.14 |
| 08/13/2025 | Q2 | -- | -- | -$0.49 | -$0.42 | -$0.07 |
| 05/15/2025 | Q1 | -- | -- | -$0.57 | -- | -- |
| 03/13/2025 | Q4 | -- | -- | -$0.46 | -- | -- |
| 11/13/2024 | Q3 | -- | -- | -$0.48 | -$0.50 | $0.02 |
| 08/13/2024 | Q2 | -- | -- | -$0.42 | -- | -- |
| 05/14/2024 | Q1 | -- | -- | -$0.54 | -- | -- |
| 03/14/2024 | Q4 | -- | -- | -$0.47 | -- | -- |
| 11/09/2023 | Q3 | -- | -- | -$0.51 | -- | -- |
| 08/10/2023 | Q2 | -- | -- | -$0.41 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.80 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | $4.90 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$3.27 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$2.86 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$3.01 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$2.18 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$2.19 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$2.97 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$2.33 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$2.63 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$2.86 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$2.37 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$3.64 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$1.53 | -- | -- |
Enliven Therapeutics, Inc. Earnings Questions
-
How Much did Enliven Therapeutics, Inc. Generate in Revenue Last Quarter?
Enliven Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Enliven Therapeutics, Inc. Beat Earnings Last Quarter?
Enliven Therapeutics, Inc. announced earnings per share of -$0.32 which represents a beat of analyst forecast a -$0.47 per share.
-
Is Enliven Therapeutics, Inc. Profitable?
Enliven Therapeutics, Inc. reported -$62K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Enliven Therapeutics, Inc. EPS Next Year?
Enliven Therapeutics, Inc.'s earnings are forecast to decrease from -$1.89 per share to -$1.59 per share next year representing a decrease of -3.64%.
-
When is Enliven Therapeutics, Inc.'s Earnings Date?
Enliven Therapeutics, Inc.'s next earnings date is March 12, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Buy
78
TVTX alert for Dec 27
Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
